| Article
Who is more likely to use cannabis for pain? A study in the journal of Cancer states its findings that, within the past year, 8% of cancer survivors reported using cannabis vs 15% of people without cancer. All those surveyed, whether cancer survivors or not, were more likely to use cannabis if they...
| Article
In a first of its kind clinical—and randomized, double-blind, placebo-controlled—trial, migraine sufferers will be given, via a vaporizer, CBD, THC, CBD and THC, and a placebo for 4 separate migraine attacks. Participants, ages 21 to 65, will self-administer as early as possible at the start of a...
| Article
A trial highlighted in the journal Experimental and Clinical Psychopharmacology looks at the analgesic effects of cannabidiol. While people may take CBD for pain relief, “no experimental pain research has tested the analgesic effects” in humans. Researchers experimentally tested CBD’s effects on...
| Video
The current landscape of pain management is shifting. There’s a huge reaction to opioids and the negative impact they’ve had on many people’s lives. Alongside that, there’s a rise in the interest in cannabinoids. Might the legalization of marijuana ultimately reduce opioid deaths? How can pain...
| Video
Gary Jay, MD, FAAPM, a clinical professor at the University of North Carolina, discusses the all-time high interest in cannabinoids. Does this interest impact the perceived opioid crisis? Do we know enough about CBD and THC to make decisions? What are the facts? What about edibles for headaches?
| Article
In an online edition of the British Journal of Anaesthesia, the Perioperative Pain and Addiction Interdisciplinary Network—or PAIN—outlined recommendations for patients who use cannabis. The regulation and use of marijuana products is constantly evolving. Cannabis use can alter perioperative...
| Article
A study in the Journal of the American Geriatrics Society of 568 people surveyed found that 15% used cannabis within the past 3 years, over 50% of those surveyed used it regularly (daily or weekly), and 78% used it for self-medicating. Patients reported most commonly smoking, taking tinctures, or...
| Video
Some practitioners are interested in learning more about cannabinoids, yet many are still hesitant. What’s new in controlled trials? How can the information be found? Theresa Mallick-Searle, MS, NP-BC, ANP-BC, discusses this plus the potential use of marijuana based meds in epilepsy and other...
| Article
Interest in cannabinoids is at an all-time high. Does this interest impact the perceived opioid crisis? Do we know enough about CBD and THC to make decisions? What has Dr. Jay experienced?
We don’t know enough to be certain of anything:
- I personally hesitate to tell patients, “Oh, you should...
| Article
The American Heart Association has issued a scientific statement calling for education for clinicians on the health implications of cannabis products. They are calling for funding and clinical trials, both of which are predicated on the removal of legal hurdles. The AHA states, “Our understanding of...